Amlodipine
Amlodipine
- In Canada and most countries amlodipine (e.g., Norvasc) is supplied in community and online pharmacies as a prescription-only medicine; tablets (commonly 2.5 mg, 5 mg, 10 mg) are widely available—some pharmacies or online sellers may offer it without a prescription, but this is not recommended and you should consult a healthcare professional.
- Amlodipine is used to treat hypertension and chronic stable or vasospastic angina; it is a dihydropyridine calcium‑channel blocker that inhibits L‑type calcium channels in vascular smooth muscle, causing arterial vasodilation and reduced peripheral resistance.
- Usual dosage: adults typically start at 5 mg once daily (start at 2.5–5 mg in the elderly or in hepatic impairment) with maintenance 5–10 mg once daily; children 6–17 years: 2.5–5 mg once daily; not recommended for children under 6 years.
- Administered orally — tablets are the most common form (2.5 mg, 5 mg, 10 mg); an oral solution (1 mg/mL) and fixed‑dose combination tablets are available in some markets.
- Onset time: blood‑pressure lowering effects generally begin within 24–48 hours (some pharmacologic activity appears within 6–12 hours), with symptomatic angina relief often seen within a day or two.
- Duration of action: long‑acting — once‑daily dosing; amlodipine has a half‑life of roughly 30–50 hours, provides at least 24 hours of effect, and full antihypertensive effect may take 1–2 weeks.
- Alcohol warning: avoid excessive alcohol — alcohol can worsen blood‑pressure lowering, dizziness and fainting; use caution and avoid heavy drinking while taking amlodipine.
- Most common side effec is peripheral oedema (ankle/leg swelling); other frequent effects include headache, flushing, dizziness, palpitations, fatigue and nausea.
- Would you like to try amlodipine without a prescription? Please note: amlodipine is prescription‑only in most jurisdictions and I cannot assist in obtaining prescription medicines without a valid prescription—consult your doctor or pharmacist for safe advice and access.
Basic Amlodipine Information
- INN (International Nonproprietary Name): Amlodipine
- Brand Names Available In Canada (English): Norvasc / Norvasc; manufacturers/distributors listed include Pfizer, Sivem, Jamp, Sandoz
- ATC Code: C08CA01
- Forms & Dosages: Tablet strengths 2.5 mg, 5 mg, 10 mg (blister packs of 10–100 common); oral solution 1 mg/mL (limited); fixed combinations with valsartan, perindopril, atorvastatin available
- Manufacturers In Canada (English): Pfizer, Sivem, Jamp, Sandoz (local distributors and generic suppliers listed in product registries)
- Registration Status In Canada (English): Approved by Health Canada (Rx-only)
- OTC / Rx Classification: Prescription Only (Rx)
Key Findings From Recent Trials
Major 2022–2025 Canadian & Global Studies
Main Outcomes
Are you wondering whether recent evidence still supports amlodipine for hypertension and angina?
Randomized trials and pooled analyses between 2022 and 2025 continued to show consistent reductions in systolic and diastolic blood pressure with amlodipine compared with placebo and many active comparators.
Studies also reported reductions in angina episode frequency for patients with chronic stable and vasospastic angina when amlodipine was used as monotherapy or in combination regimens.
Canadian observational registry data reinforced good adherence with once-daily dosing, and several cost-effectiveness models found amlodipine-based combinations to be value-for-money for cardiovascular event prevention.
Evidence-grade comes from multiple randomized controlled trials plus real-world cohort studies, though trial endpoint definitions varied across reports.
Safety Observations
Did the safety profile change in recent surveillance?
Across 2022–2025 surveillance and pooled analyses there were no new class-wide serious safety warnings.
Peripheral oedema remained the most frequent tolerability issue, and rare hepatic adverse-event reports reiterated existing guidance on cautious dosing in significant hepatic impairment.
Head-to-head trials versus other dihydropyridines tended to show similar antihypertensive efficacy and often lower heart-rate effects with amlodipine.
Clinical Mechanism Of Action
Layman’s Explanation
How does amlodipine actually make blood pressure lower?
Amlodipine relaxes and widens the small arteries in the body, which lowers the pressure the heart must pump against and improves blood flow to the heart muscle.
This vasodilation reduces chest pain from angina by improving oxygen delivery to cardiac tissue.
Scientific Breakdown
What is the pharmacology behind that effect?
Amlodipine is a long-acting dihydropyridine calcium-channel blocker assigned ATC code C08CA01.
It inhibits L-type calcium channels predominantly in vascular smooth muscle rather than cardiac conduction tissue, producing arterial vasodilation and lowering systemic vascular resistance.
The slow onset of action and prolonged elimination half-life result in steady plasma levels that support once-daily dosing and reduce peak-related side effects.
Vascular Selectivity And Pharmacokinetics
Why does it cause swelling at the ankles?
Preferential action on peripheral arterioles explains the primary blood-pressure lowering effect and the tendency toward reflexive changes in heart rate that are usually modest.
Oral bioavailability is sufficient for reliable once-daily dosing, and the drug is substantially metabolized in the liver, so dose caution is advised in hepatic impairment.
These mechanistic properties underlie approved indications for hypertension and angina and account for common dose-related adverse effects such as peripheral oedema and flushing.
Scope Of Approved And Off-Label Use
Health Canada Approvals (DIN-Based)
Patients often ask which uses are officially approved in Canada.
Health Canada approves amlodipine, typically as amlodipine besylate, for hypertension and chronic stable or vasospastic angina under DINs including brand Norvasc and multiple generics.
Marketed tablet strengths in Canada include 2.5 mg, 5 mg and 10 mg, consistent with product monographs and national formularies.
Notable Off-Label Trends In Canadian Practice
Do prescribers use amlodipine for other conditions?
Clinicians in Canada sometimes prescribe low-dose amlodipine (2.5 mg) in frail elderly patients or as adjunct therapy for Raynaud-like vasospasm and select cases of migraine prophylaxis, though robust evidence is limited.
Pediatric use is generally restricted to ages 6–17 years with recommended dosing of 2.5–5 mg once daily; use in children under 6 is not advised per product information.
Fixed-dose combinations such as amlodipine with valsartan or perindopril are used to simplify therapy and improve adherence, with provincial formulary listings and restrictions varying by DIN and jurisdiction.
Dosage Strategy
General Dosing Per Health Canada Monographs
What dose should most adults start on?
Adults typically start at 5 mg once daily for hypertension or angina, with maintenance dosing of 5–10 mg once daily depending on response.
Elderly patients and those with hepatic impairment should begin at the lowest effective dose, often 2.5–5 mg, and titrate slowly.
Pediatric patients aged 6–17 years commonly use 2.5–5 mg once daily; treatment for children under 6 years is not recommended.
Condition-Specific Dosing Adjustments
How are doses adjusted for specific situations?
Isolated systolic hypertension in older adults often prompts initiation at 2.5–5 mg to reduce the risk of orthostatic hypotension.
In moderate to severe liver impairment, titration is cautious and maximal doses may be lower due to hepatic metabolism.
When switching to a single-pill combination, it is prudent to start the components individually to assess tolerance before changing to a fixed-dose product.
Missed-dose advice: take when remembered unless close to the next dose; do not double the next dose.
Safety Protocols
Contraindications (Canadian Advisories)
Who should not take amlodipine?
Absolute contraindications include hypersensitivity to amlodipine or other dihydropyridines, severe hypotension, shock including cardiogenic shock, significant aortic stenosis, and hemodynamically unstable heart failure after acute myocardial infarction.
Use is also cautioned in severe hepatic impairment and in elderly patients where lower starting doses are recommended.
Adverse Effects (Post-Market Reports)
What side effects should patients expect and report?
Common dose-related adverse effects include peripheral oedema, headache, flushing, dizziness, palpitations, fatigue and gastrointestinal upset.
Most of these resolve with continued therapy or lower doses, but rare reports of symptomatic hypotension and hepatic enzyme elevations have been documented in post-market surveillance.
Pharmacists should advise baseline blood-pressure monitoring and consider liver-function monitoring for patients with pre-existing hepatic disease, and report suspected serious events to Health Canada.
Interaction Mapping
Food Interactions Common In Canadian Diet
Do any foods affect amlodipine?
No major food restrictions are required, and typical Canadian diets do not mandate dose timing changes for amlodipine tablets.
Grapefruit juice has a minimal effect compared with some other calcium-channel blockers, but consistency in dietary habits helps avoid blunting antihypertensive response from high-sodium meals.
Drug Combinations Flagged By Health Canada
Which medications require caution?
Strong CYP3A4 inhibitors such as certain antifungals or macrolide antibiotics can increase amlodipine exposure and the likelihood of hypotension and oedema.
CYP3A4 inducers may reduce effectiveness.
Additive hypotension occurs with ACE inhibitors, ARBs, beta-blockers and diuretics, so blood-pressure monitoring is important after initiation or dose changes.
There is a notable interaction caution with simvastatin at higher simvastatin doses; monitor for myopathy and follow monograph dose limits or consider alternative statins.
Patient Experience Analysis
Canadian Survey Data
What do Canadian patients say about amlodipine?
Survey and pharmacy feedback report high satisfaction with once-daily amlodipine for blood-pressure control and angina symptom relief, with adherence helped by a simple daily routine.
Peripheral ankle swelling is the most common patient-reported problem and often triggers pharmacist calls seeking advice on whether to continue therapy.
Forum & Community Pharmacy Trends
What do community pharmacists see on a typical day?
Pharmacists in national chains frequently manage brand-to-generic switches and counsel on managing oedema without abruptly stopping therapy, suggesting compression and salt reduction where appropriate.
Patients also ask about switching brands or cross-border pricing, and provincial drug-benefit programs (ODB, BC PharmaCare, RAMQ) can influence out-of-pocket costs and adherence patterns.
Distribution And Pricing Landscape
National Pharmacy Chains
Where can patients pick up amlodipine in Canada?
Major national and regional pharmacy chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs stock single-ingredient amlodipine and fixed-dose combination DINs in standard packaging.
Bilingual labelling and DIN verification are routine at these outlets.
Online Pharmacy Availability & Provincial Restrictions
Can patients order online?
Licensed Canadian online pharmacies list multiple generic suppliers and brands, but provincial restrictions on prescription validity and dispensing quantities still apply.
In our online pharmacy, amlodipine is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Cross-Border US Comparisons
Is there a big price gap with the United States?
Retail prices for brand Norvasc in the U.S. can differ, but robust generic competition in Canada from suppliers such as Sandoz, Apotex and Sivem narrows pricing differences.
Alternative Options
Comparison Table Of DIN-Approved Alternatives
Which alternatives should be considered when amlodipine is unsuitable?
Canadian DIN-approved alternatives in the calcium-channel blocker class include lercanidipine, felodipine and nifedipine, plus non-dihydropyridines such as verapamil for rate control.
Amlodipine stands out for once-daily dosing and long half-life compared with short-acting nifedipine formulations, though extended-release nifedipine remains a comparator.
Pros And Cons Checklist
- Pros: Steady blood-pressure control, wide availability in 2.5–10 mg tablets, many generic and fixed-combination DINs.
- Cons: Higher incidence of peripheral oedema than some alternatives; dose caution in hepatic impairment.
When switching, evaluate efficacy equivalence, side-effect profiles, interaction potential (especially CYP3A4), and formulary coverage.
Regulatory Status
Health Canada Approval Process
How was amlodipine evaluated for the Canadian market?
Manufacturers submit evidence dossiers demonstrating safety, efficacy and quality before receiving a Drug Identification Number (DIN) from Health Canada.
Post-market surveillance and adverse-event reporting systems continue to monitor safety after approval.
DIN And Bilingual Labelling Rules
What must pharmacists check at dispensing?
All marketed products require a DIN and bilingual English–French labelling in Canada, and pharmacies verify DINs during dispensing for legal and formulary compliance.
Provincial drug-benefit plans often require DIN-specific listings for reimbursement and may impose prior-authorization criteria for certain fixed-dose combinations.
Consolidated FAQ
Is amlodipine covered by provincial drug plans?
Many provincial formularies list specific DINs for amlodipine; coverage varies by province and by product, so check ODB, BC PharmaCare or RAMQ listings for details.
Can I switch between brand and generic products?
Yes; pharmacists may substitute generics within provincial substitution rules, and patients should monitor for side effects after a switch and note the DIN and appearance of the new product.
What should I do about ankle swelling on amlodipine?
Peripheral oedema is common and dose-related; consult a pharmacist or prescriber before stopping treatment as dose reduction or switching classes may help.
Can I take amlodipine with statins?
Co-prescription is generally acceptable but monitor simvastatin dosage because of interaction cautions; alternative statins or dose adjustments are options per product monographs.
What about pregnancy and breastfeeding?
Robust data are limited; prescribers should weigh benefits and risks and consider alternatives where appropriate, and exposures may be reported to local teratology information services.
Visual Guide
What visuals help patients understand amlodipine at a glance?
Recommended infographic elements include a dosage ladder showing start and maintenance doses, special notes for elderly and hepatic impairment, and pediatric boxes for ages 6–17 years.
A provincial coverage map highlighting ODB, BC PharmaCare and RAMQ with DIN notes helps patients check reimbursement pathways.
Purchase-channel visuals should contrast in-store chains versus licensed online pharmacies and emphasise DIN and bilingual-labelling checks.
Packaging illustrations can show common blister sizes and tablet strengths, and a small interactions panel should highlight CYP3A4 inhibitors, simvastatin caution, and additive antihypertensives.
Storage And Transport
Canadian Household Guidelines
How should patients store amlodipine at home?
Store tablets below 25°C (77°F), protect from moisture and light, and keep them in original packaging until use.
Avoid storing medicines in bathrooms or near heat sources, keep out of reach of children, and return expired tablets to a pharmacy take-back program for disposal.
Cold-Chain Storage Where Applicable
Does amlodipine need refrigeration?
Oral tablets do not require refrigeration; oral solution formulations are rare and should follow specific manufacturer instructions.
For pharmacy shipping and remote deliveries, licensed pharmacies must follow Good Distribution Practices and consider insulated packaging during extreme seasonal temperatures.
Guidelines For Proper Use
Advice From Canadian Pharmacists
What practical counselling points should patients receive?
Take amlodipine at the same time every day, monitor blood pressure and watch for ankle swelling or dizziness from orthostatic changes.
Report persistent oedema or symptomatic hypotension to a pharmacist or prescriber and document any brand or DIN changes when substitutions occur.
Provincial Health Authority Guidance
What do provincial pathways recommend?
Follow local formulary initiation criteria and reimbursement rules; single-pill combinations are often preferred when adherence is a barrier.
For suspected overdose presenting with severe hypotension or reflex tachycardia, seek immediate medical care and provide cardiovascular support as directed by emergency protocols.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-9 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| St. John’s | Newfoundland and Labrador | 5-9 days |
| Charlottetown | Prince Edward Island | 5-9 days |
| Yellowknife | Northwest Territories | 5-9 days |